B Precursor Type Acute Leukaemia

also: B Precursor Type Acute Leukemia

1 drug1 FAERS reportsMedDRA PT

GET

/api/v1/reaction/b-precursor-type-acute-leukaemia

Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.

Drugs reporting B Precursor Type Acute Leukaemia (1)

Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.

1Atidarsagene Autotemcel114%

What this is

B Precursor Type Acute Leukaemia is a MedDRA Preferred Term reported on FAERS adverse-event submissions. Each entry below is one drug from the dataset whose FAERS reports mention this reaction.

Try the API

cURLbash

curl https://pharmacopeia.dev/api/v1/reaction/b-precursor-type-acute-leukaemia

Source

Source: openFDA · FAERS
Coding: MedDRA Preferred Term
Aliases: B Precursor Type Acute Leukemia

open.fda.gov/data/faers/

Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.

B Precursor Type Acute Leukaemia

Drugs reporting B Precursor Type Acute Leukaemia (1)

Search pharmacopeia